Lappe Mark

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lappe Mark's trades of Inhibrx Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.02
Quantity 60 -0.0%
Value US$1,501
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
26.11
Quantity 63 -0.0%
Value US$1,645
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.71
Quantity 4,272 -0.2%
Value US$109,833
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.36
Quantity 21,665 -0.9%
Value US$549,364
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
26.29
Quantity 754 -0.0%
Value US$19,820
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.53
Quantity 25,246 -1.0%
Value US$644,624
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
32.38
Quantity 1,150 -0.0%
Value US$37,241
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
30.67
Quantity 912 -0.0%
Value US$27,969
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
30.15
Quantity 6,773 -0.3%
Value US$204,196
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
28.86
Quantity 1,767 -0.1%
Value US$50,991
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
27.45
Quantity 4,333 -0.2%
Value US$118,937
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
26.57
Quantity 4,106 -0.2%
Value US$109,098
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.36
Quantity 6,959 -0.3%
Value US$176,477
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
31.51
Quantity 121 -0.0%
Value US$3,812
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
30.81
Quantity 2,892 -0.1%
Value US$89,090
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
29.92
Quantity 14,006 -0.5%
Value US$419,123
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
28.66
Quantity 8,981 -0.3%
Value US$257,419
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-08
B Purchase
48,989 +28.0%
465.33
US$4,725,457 		48,989 +28.0% 465.33 US$4,725,457
2026-09-08 2026-09-08
B Purchase
97,627 -31.2%
128.32
US$609,556 		97,627 -31.2% 128.32 US$609,556
2026-09-08 2026-09-08
B Purchase
17,485 +40.6%
84.49
US$368,226 		17,485 +40.6% 84.49 US$368,226
2026-09-08 2026-09-08
B Purchase
1,100 +0.2%
107.12
US$117,836 		1,100 +0.2% 107.12 US$117,836
2026-09-08 2026-09-08
B Purchase
6,605 +0.9%
100.64
US$664,719 		6,605 +0.9% 100.64 US$664,719
2026-09-08 2026-09-08
B Purchase
5,895 +0.8%
99.29
US$585,343 		5,895 +0.8% 99.29 US$585,343
2024-09-16 2024-09-16
B Purchase
13,037 +1.9%
17.13
US$223,324 		13,037 +1.9% 17.13 US$223,324
2024-09-16 2024-09-12
B Purchase
26,963 +4.1%
15.05
US$405,793 		26,963 +4.1% 15.05 US$405,793
2024-09-10 2024-09-10
B Purchase
8,500 +1.3%
15.19
US$129,115 		8,500 +1.3% 15.19 US$129,115
2024-09-10 2024-09-09
B Purchase
9,500 +1.5%
15.21
US$144,495 		9,500 +1.5% 15.21 US$144,495
2024-09-10 2024-09-06
B Purchase
26,000 +4.2%
15.29
US$397,540 		26,000 +4.2% 15.29 US$397,540
2024-09-03 2024-09-03
B Purchase
4,712 +2.9%
16.31
US$76,853 		4,712 +2.9% 16.31 US$76,853
2024-09-03 2024-09-03
B Purchase
15,288 +10.5%
15.66
US$239,410 		15,288 +10.5% 15.66 US$239,410
2024-09-03 2024-08-30
B Purchase
10,000 +7.4%
14.02
US$140,200 		10,000 +7.4% 14.02 US$140,200
2024-09-03 2024-08-29
B Purchase
10,000 +8.0%
14.03
US$140,300 		10,000 +8.0% 14.03 US$140,300
2024-08-22 2024-08-21
B Purchase
12,945 +30.9%
12.93
US$167,379 		12,945 +30.9% 12.93 US$167,379
2024-08-22 2024-08-20
B Purchase
27,055 +182.0%
12.97
US$350,903 		27,055 +182.0% 12.97 US$350,903
2023-03-01 2023-02-28
US Inhibrx Inc (INBX)
PlS Planned sale
60 -0.0%
25.02
US$1,501 		60 -0.0% 25.02 US$1,501
2023-01-24 2023-01-24
US Inhibrx Inc (INBX)
PlS Planned sale
63 -0.0%
26.11
US$1,645 		63 -0.0% 26.11 US$1,645
2023-01-24 2023-01-24
US Inhibrx Inc (INBX)
PlS Planned sale
4,272 -0.2%
25.71
US$109,833 		4,272 -0.2% 25.71 US$109,833
2023-01-24 2023-01-23
US Inhibrx Inc (INBX)
PlS Planned sale
21,665 -0.9%
25.36
US$549,364 		21,665 -0.9% 25.36 US$549,364
2022-12-20 2022-12-19
US Inhibrx Inc (INBX)
PlS Planned sale
754 -0.0%
26.29
US$19,820 		754 -0.0% 26.29 US$19,820
2022-12-20 2022-12-19
US Inhibrx Inc (INBX)
PlS Planned sale
25,246 -1.0%
25.53
US$644,624 		25,246 -1.0% 25.53 US$644,624
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
1,150 -0.0%
32.38
US$37,241 		1,150 -0.0% 32.38 US$37,241
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
912 -0.0%
30.67
US$27,969 		912 -0.0% 30.67 US$27,969
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
6,773 -0.3%
30.15
US$204,196 		6,773 -0.3% 30.15 US$204,196
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
1,767 -0.1%
28.86
US$50,991 		1,767 -0.1% 28.86 US$50,991
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
4,333 -0.2%
27.45
US$118,937 		4,333 -0.2% 27.45 US$118,937
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
4,106 -0.2%
26.57
US$109,098 		4,106 -0.2% 26.57 US$109,098
2022-11-18 2022-11-17
US Inhibrx Inc (INBX)
PlS Planned sale
6,959 -0.3%
25.36
US$176,477 		6,959 -0.3% 25.36 US$176,477
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
121 -0.0%
31.51
US$3,812 		121 -0.0% 31.51 US$3,812
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
2,892 -0.1%
30.81
US$89,090 		2,892 -0.1% 30.81 US$89,090
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
14,006 -0.5%
29.92
US$419,123 		14,006 -0.5% 29.92 US$419,123
2022-10-18 2022-10-17
US Inhibrx Inc (INBX)
PlS Planned sale
8,981 -0.3%
28.66
US$257,419 		8,981 -0.3% 28.66 US$257,419